With more than 850 biotechnology companies, the Bay Area is the oldest, largest and most productive life sciences cluster in the world, employing more than 125,000 people in the region. For more than 30 years, this region has led the world in researching and delivering new cures and treatments for debilitating diseases including cancer, Multiple Sclerosis and HIV/AIDS. But the industry is facing serious challenges with early stage innovation in the current economic climate.
For years, our strong roots, supported by our vibrant businesses, academic community, and engaged elected officials – have brought countless biotech firms to the Bay area, cementing our nationwide role as a leader in biotechnology and biomedical scientific breakthroughs. In short, this is where all the action’s taking place.
To read the full, original article click on this link: The Early Stage Innovation Crisis | Xconomy
